Shijiazhuang Yiling Pharmaceutical Co., Ltd., commonly referred to as Yiling Pharmaceutical, is a leading player in the Chinese pharmaceutical industry, headquartered in Shijiazhuang, CN. Established in 1992, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, focusing on areas such as cardiovascular health, oncology, and respiratory diseases. Yiling Pharmaceutical is renowned for its innovative core products, including the widely acclaimed Yiling Qingfei Paidu Decoction, which exemplifies the integration of traditional practices with contemporary science. With a strong commitment to research and development, the company has achieved notable milestones, positioning itself as a trusted name in both domestic and international markets. Its dedication to quality and efficacy has earned Yiling Pharmaceutical a prominent market position, making it a key contributor to the advancement of healthcare solutions.
How does Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shijiazhuang Yiling Pharmaceutical Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Shijiazhuang Yiling Pharmaceutical has not cascaded any emissions data from a parent or related organization, nor does it appear to have established any industry-standard climate initiatives such as Science Based Targets (SBTi) or commitments to the Carbon Disclosure Project (CDP). In the context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. However, without specific data or commitments, it is unclear how Shijiazhuang Yiling Pharmaceutical is positioning itself in relation to these industry trends.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shijiazhuang Yiling Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.